Clinical Trial Update: Safety and Efficacy of SC0806 (Fibroblast Growth Factor 1 and a Device) in Traumatic Spinal Cord Injury Subjects [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety and efficacy data for SC0806, a combination of Fibroblast Growth Factor 1 and a device, in adults with traumatic spina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• SC0806 (Fibroblast Growth Factor 1 (FGF-1))

Snippet

Sponsor: BioArctic AB | Conditions: Spinal Cord Injury | Phase 1, Phase 2 | Status: COMPLETED